NEU 3.07% $13.09 neuren pharmaceuticals limited

Very true TL.Everything is trending beyond expectations.Revenue...

  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    Very true TL.
    Everything is trending beyond expectations.
    Revenue numbers, rate of recruitment, lesser rate of drop out. Everything
    Acadia can’t spell it out more. The majority of the remaining Rett market will only now begin to be targeted.
    As each quarter rolls on, we get closer to adding ROW regions.
    800 patients ~ US$70m for the quarter
    This isn’t a forecast. It just happened
    3200 patients ~ US$280m for a quarter
    This is a forecast and a realistic medium term goal.
    Not sure what else people need to see to make them aware of what’s going on here - irrespective of 2591 or fragile-x

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.